BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17673549)

  • 1. Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system.
    Norris EH; Strickland S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13473-8. PubMed ID: 17673549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors.
    Pawlak R; Melchor JP; Matys T; Skrzypiec AE; Strickland S
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):443-8. PubMed ID: 15630096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory.
    Zhao MG; Toyoda H; Lee YS; Wu LJ; Ko SW; Zhang XH; Jia Y; Shum F; Xu H; Li BM; Kaang BK; Zhuo M
    Neuron; 2005 Sep; 47(6):859-72. PubMed ID: 16157280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.
    Ng KS; Leung HW; Wong PT; Low CM
    J Biol Chem; 2012 Jul; 287(30):25520-9. PubMed ID: 22610100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.
    Zhuo M; Holtzman DM; Li Y; Osaka H; DeMaro J; Jacquin M; Bu G
    J Neurosci; 2000 Jan; 20(2):542-9. PubMed ID: 10632583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
    Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
    Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Fyn tyrosine kinase in the mouse dorsal hippocampus is essential for contextual fear conditioning.
    Isosaka T; Hattori K; Kida S; Kohno T; Nakazawa T; Yamamoto T; Yagi T; Yuasa S
    Eur J Neurosci; 2008 Sep; 28(5):973-81. PubMed ID: 18691323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered emotionality, hippocampus-dependent performance and expression of NMDA receptor subunit mRNAs in chronically stressed mice.
    Costa-Nunes J; Zubareva O; Araújo-Correia M; Valença A; Schroeter CA; Pawluski JL; Vignisse J; Steinbusch H; Hermes D; Phillipines M; Steinbusch HM; Strekalova T
    Stress; 2014 Jan; 17(1):108-16. PubMed ID: 24308441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for disrupted NMDA receptor function in tissue plasminogen activator knockout mice.
    Horwood JM; Ripley TL; Stephens DN
    Behav Brain Res; 2004 Apr; 150(1-2):127-38. PubMed ID: 15033286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus.
    Pawlak R; Rao BS; Melchor JP; Chattarji S; McEwen B; Strickland S
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18201-6. PubMed ID: 16330749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation.
    Qian Z; Gilbert ME; Colicos MA; Kandel ER; Kuhl D
    Nature; 1993 Feb; 361(6411):453-7. PubMed ID: 8429885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.
    Matys T; Pawlak R; Matys E; Pavlides C; McEwen BS; Strickland S
    Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16345-50. PubMed ID: 15522965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
    Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke.
    Macrez R; Bezin L; Le Mauff B; Ali C; Vivien D
    Stroke; 2010 Dec; 41(12):2950-5. PubMed ID: 20966414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
    Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction- and conditioning-protocol dependent involvement of NR2B-containing NMDA receptors in synaptic potentiation and contextual fear memory in the hippocampal CA1 region of rats.
    Zhang XH; Wu LJ; Gong B; Ren M; Li BM; Zhuo M
    Mol Brain; 2008 Sep; 1():9. PubMed ID: 18826591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurabin contributes to hippocampal long-term potentiation and contextual fear memory.
    Wu LJ; Ren M; Wang H; Kim SS; Cao X; Zhuo M
    PLoS One; 2008 Jan; 3(1):e1407. PubMed ID: 18183288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13.
    Fan M; Xu H; Wang L; Luo H; Zhu X; Cai P; Wei L; Lu L; Cao Y; Ye R; Fan W; Zhao BQ
    Sci Rep; 2016 May; 6():25971. PubMed ID: 27181025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.
    Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E
    J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
    Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.